» Articles » PMID: 30776412

Stimulus-responsive Nanoscale Delivery Systems Triggered by the Enzymes in the Tumor Microenvironment

Overview
Specialty Pharmacology
Date 2019 Feb 19
PMID 30776412
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

The tumor microenvironment is the cellular environment that is also described as the "soil" for supporting tumor growth, proliferation, invasion and metastasis, as well as protecting tumor cells from immunological recognition. Notably, tumor cells can grow much faster than other normal organs and invade surrounding tissues more easily, which results in abnormal expression of enzymes in the tumor microenvironment, including matrix metalloproteinases, cathepsins, phospholipases, oxidoreductases, etc. In opposite, due to the high selectivity and catalytic activity, these enzymes can promote nanoparticles to recognize tumor tissues more accurately, and the more accumulation of drugs at primal tumor sites will enhance therapeutic efficacy with lower systemic toxicity. Therefore, one promising antitumor strategy is to design stimulus-responsive nanoscale delivery systems triggered by the enzymes with the support of various nanocarriers, such as liposomes, micelles and inorganic nanoparticles, etc. In this review, numerous facts were cited to summarize and discuss the typical types of enzyme-stimulus responsive nanoscale delivery systems. More importantly, we also focused on their recent advancements in antitumor therapy, and offered the direction for further studies.

Citing Articles

Innovations in Cancer Therapy: Endogenous Stimuli-Responsive Liposomes as Advanced Nanocarriers.

Torres J, Valenzuela Oses J, Rabasco-Alvarez A, Gonzalez-Rodriguez M, Garcia M Pharmaceutics. 2025; 17(2).

PMID: 40006612 PMC: 11858840. DOI: 10.3390/pharmaceutics17020245.


Combined Albumin Polyester Nanocarriers with Docetaxel for Effective Against Lung Cancer in Mice Model.

Yang Y, Ye T, Shang F, Chen D, Wang K, He S Int J Nanomedicine. 2025; 20:2103-2118.

PMID: 39990292 PMC: 11844320. DOI: 10.2147/IJN.S487344.


Integrin-Specific Stimuli-Responsive Nanomaterials for Cancer Theranostics.

Taheri Z, Mozafari N, Moradian G, Lovison D, Dehshahri A, De Marco R Pharmaceutics. 2024; 16(11).

PMID: 39598564 PMC: 11597626. DOI: 10.3390/pharmaceutics16111441.


Dual Responsive Magnetic Drug Delivery Nanomicelles with Tumor Targeting for Enhanced Cancer Chemo/Magnetothermal Synergistic Therapy.

Zhu J, Yang Y, Wang J, Hong W, Li Y, Wang Z Int J Nanomedicine. 2023; 18:7647-7660.

PMID: 38111845 PMC: 10726825. DOI: 10.2147/IJN.S436414.


Smart nanoparticles for cancer therapy.

Sun L, Liu H, Ye Y, Lei Y, Islam R, Tan S Signal Transduct Target Ther. 2023; 8(1):418.

PMID: 37919282 PMC: 10622502. DOI: 10.1038/s41392-023-01642-x.